1117-1124
Review
Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases
O. Filleul, E. Crompot and S. Saussez
1125-1134
Original Paper
The clinical significance of 18F-FDG-PET/CT in early detection of second primary malignancy in cancer patients
Haoping Xu, Miao Zhang, Ge Zhai and Biao Li
1135-1142
Original Paper
MGMT −535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy
Jee Hyun Park, Nung Soo Kim, Jae Yong Park, Yee Soo Chae and Jong Gwang Kim, et al.
1143-1150
Original Paper
Efficacy of a methyl ester of 5-aminolevulinic acid in photodynamic therapy for ovarian cancers
M. Wakui, Yoshihito Yokoyama, H. Wang, T. Shigeto and M. Futagami, et al.
1151-1159
Original Paper
Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LC-MS/MS
Xiaonan Kang, Lu Sun, Kun Guo, Hong Shu and Jun Yao, et al.
1161-1167
Original Paper
Epigenetic silencing of WIF-1 in hepatocellular carcinomas
Yun Deng, Bin Yu, Qin Cheng, Jie Jin and Haiyan You, et al.
1169-1178
Original Paper
Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy
Jun Dang, Guang Li, Xiaobe Lu, Lei Yao and Shuo Zhang, et al.
1179-1185
Original Paper
(−)-Epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells
Guo-Qing Tang, Tai-Qiang Yan, Wei Guo, Ting-Ting Ren and Chang-Liang Peng, et al.
1187-1192
Original Paper
Identification of HTA as a novel-specific marker for human hepatocellular carcinoma
Yan Liu, Yuehui Li, Fengjie Guo, Miao Dai and Jiajia Wang, et al.
1193-1199
Original Paper
Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin’s lymphoma patients
Zhu-Lin Pan, Xing-Ying Ji, Yan-Min Shi, Ji Zhou and Ellen He, et al.
1201-1211
Original Paper
Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma
Guichun Huang and Longbang Chen
1213-1219
Original Paper
Expression and prognostic relevance of CD44v6 in stage I non-small cell lung carcinoma
Dongrong Situ, Hao Long, Peng Lin, Zhihua Zhu and Jiang Wang, et al.
1221-1227
Original Paper
Identification of aberrant promoter hypomethylation of HOXA10 in ovarian cancer
Wenjun Cheng, Yi Jiang, Cuixia Liu, Ouxi Shen and Weiwei Tang, et al.
1229-1242
Original Paper
Suppression of human MDA-MB-435S tumor by U6 promoter-driven short hairpin RNAs targeting focal adhesion kinase
An-liang Huang, Yang Wan, Dian-ying Liao, Huo-zhen Hu and Lin Wei, et al.
1243-1254
Original Paper
Detection and identification of potential biomarkers of breast cancer
Yuxia Fan, Jiachen Wang, Yang Yang, Qiuliang Liu and Yingzhong Fan, et al.
1255-1265
Original Paper
Small interference RNA targeting Krüppel-like factor 8 inhibits the renal carcinoma 786-0 cells growth in vitro and in vivo
Wei-Jin Fu, Jia-Chu Li, Xiao-yun Wu, Zhan-Bing Yang and Zeng-Nan Mo, et al.
1267-1273
Original Paper
Semi-quantitative detection of GADD45-gamma methylation levels in gastric, colorectal and pancreatic cancers using methylation-sensitive high-resolution melting analysis
Wei Zhang, Tianrun Li, Yong Shao, Chao Zhang and Qi Wu, et al.
1275-1282
Original Paper
Potential roles for PA28β in gastric adenocarcinoma development and diagnosis
Qiaojia Huang, Qingling Huang, Wansong Lin, Jianyin Lin and Xu Lin
1283-1292
Original Paper
Clinical significance of pAKT and CD44v6 overexpression with breast cancer
Pei Yu, Ling Zhou, Weifeng Ke and Ke Li
1293-1294
Letter to the Editor
BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer
Chen Mao, Ru-Yan Liao and Qing Chen